Annual report
7716.TEDINET S100XU9P
Period2025-01-01 → 2025-12-31
Filed2026-03-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥81.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥77.0bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥59.7bn | 2023-01-01 → 2023-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥48.7bn | 2022-01-01 → 2022-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥44.9bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥14.1bn | 2025-01-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥14.6bn | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥16.9bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥17.3bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥17.2bn | 2023-01-01 → 2023-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥17.6bn | 2022-01-01 → 2022-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥14.0bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.3bn | 2025-01-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥13.7bn | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥2.4bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥8.6bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥22.8bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥12.5bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥10.1bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥2.4bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥8.6bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥160.2bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥158.3bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥140.8bn | at 2023-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥102.6bn | at 2022-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥94.5bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥46.1bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥37.1bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥114.1bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥121.2bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥113.2bn | at 2023-12-31v | Cons. | Net assets |
| Net assets / equity | ¥91.0bn | at 2022-12-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥82.9bn | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥61.3bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥46.1bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥46.0bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.2bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥26.0bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥31.6bn | at 2022-12-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥34.9bn | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥16.6bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥15.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.6bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.8bn | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥12.0bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥8.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥19.1bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.3bn | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.1bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥679m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥599m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.4bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6.1bn | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.0bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-28.7 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.37 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥267.62 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥145.48 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.73 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥101.06 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥266.87 | 2023-01-01 → 2023-12-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥145.11 | 2022-01-01 → 2022-12-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.47 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,368.88 | at 2025-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,430.58 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,322.75 | at 2023-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,065.57 | at 2022-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥959.59 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 71.0% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.3% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.1% | at 2023-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.4% | at 2022-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.5% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | -2.0% | 2025-01-01 → 2025-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 22.4% | 2023-01-01 → 2023-12-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.4% | 2022-01-01 → 2022-12-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.7% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,204 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 2,180 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 2,049 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 1,478 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 1,239 | at 2021-12-31d | Cons. | Number of employees |
| Revenue | ¥42.0bn | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥34.3bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥36.7bn | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥34.4bn | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥32.9bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥13.6bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | ¥9.0bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | ¥16.6bn | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥11.4bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥15.7bn | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥15.7bn | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.8bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥16.7bn | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥8.6bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | ¥11.0bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | ¥6.2bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥12.1bn | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥11.8bn | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.2bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥115.6bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥102.1bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥95.1bn | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥77.1bn | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥71.6bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥33.0bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥23.1bn | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥82.7bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥79.0bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥78.8bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥69.9bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥64.6bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥21.5bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥16.2bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥131.49 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥73.79 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥141.8 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥137.22 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.97 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥131.05 | 2025-01-01 → 2025-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥73.57 | 2024-01-01 → 2024-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥141.41 | 2023-01-01 → 2023-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥136.88 | 2022-01-01 → 2022-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥82.79 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥54 | 2025-01-01 → 2025-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥52 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2023-01-01 → 2023-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥46 | 2022-01-01 → 2022-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥37 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥990.92 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥930.73 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥919.68 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥817.09 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥746.98 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 71.2% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.0% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.5% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.3% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.8% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 13.7% | 2025-01-01 → 2025-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.0% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.3% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.6% | 2022-01-01 → 2022-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.4% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 93,418,200 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 93,418,200 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,107 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 1,100 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 1,060 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 1,004 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 906 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 83
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-01-01 → 2025-12-31 | ¥928m |
| Reconciling Itemsreconciling | depreciation | 2025-01-01 → 2025-12-31 | ¥534m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-12-31 | −¥386m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-12-31 | −¥386m |
| Reconciling Itemsreconciling | segment assets | at 2025-12-31 | ¥81.2bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-12-31 | −¥5.8bn |
| DCI Productsreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥84m |
| DCI Productsreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥1.1bn |
| DCI Productsreportable segment | employees | at 2025-12-31 | 412 pure |
| DCI Productsreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥20.5bn |
| DCI Productsreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥20.5bn |
| DCI Productsreportable segment | segment assets | at 2025-12-31 | ¥31.1bn |
| DCI Productsreportable segment | segment profit | 2025-01-01 → 2025-12-31 | −¥490m |
| Dental Productsreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥3.2bn |
| Dental Productsreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥2.2bn |
| Dental Productsreportable segment | employees | at 2025-12-31 | 991 pure |
| Dental Productsreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥48.6bn |
| Dental Productsreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥48.2bn |
| Dental Productsreportable segment | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥386m |
| Dental Productsreportable segment | segment assets | at 2025-12-31 | ¥37.0bn |
| Dental Productsreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥16.9bn |
| Industrial Productsreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥584m |
| Industrial Productsreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥363m |
| Industrial Productsreportable segment | employees | at 2025-12-31 | 227 pure |
| Industrial Productsreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥6.9bn |
| Industrial Productsreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥6.9bn |
| Industrial Productsreportable segment | segment assets | at 2025-12-31 | ¥8.6bn |
| Industrial Productsreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥817m |
| Surgical Productsreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥529m |
| Surgical Productsreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥170m |
| Surgical Productsreportable segment | employees | at 2025-12-31 | 186 pure |
| Surgical Productsreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥5.5bn |
| Surgical Productsreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥5.5bn |
| Surgical Productsreportable segment | segment assets | at 2025-12-31 | ¥2.3bn |
| Surgical Productsreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥2.7bn |
| —segment total | capex | 2025-01-01 → 2025-12-31 | ¥4.4bn |
| —segment total | depreciation | 2025-01-01 → 2025-12-31 | ¥3.8bn |
| —segment total | revenue | 2025-01-01 → 2025-12-31 | ¥81.6bn |
| —segment total | revenue external | 2025-01-01 → 2025-12-31 | ¥81.2bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥386m |
| —segment total | segment assets | at 2025-12-31 | ¥78.9bn |
| —segment total | segment profit | 2025-01-01 → 2025-12-31 | ¥19.8bn |
| Reconciling Itemsreconciling | capex | 2024-01-01 → 2024-12-31 | ¥1.2bn |
| Reconciling Itemsreconciling | depreciation | 2024-01-01 → 2024-12-31 | ¥515m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥214m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-12-31 | −¥214m |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥66.4bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥5.7bn |
| DCI Productsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥80m |
| DCI Productsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥1.1bn |
| DCI Productsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥19.5bn |
| DCI Productsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥19.5bn |
| DCI Productsreportable segment | segment assets | at 2024-12-31 | ¥46.8bn |
| DCI Productsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥90m |
| Dental Productsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥2.9bn |
| Dental Productsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥2.0bn |
| Dental Productsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥46.7bn |
| Dental Productsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥46.5bn |
| Dental Productsreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥214m |
| Dental Productsreportable segment | segment assets | at 2024-12-31 | ¥35.2bn |
| Dental Productsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥17.1bn |
| Industrial Productsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥610m |
| Industrial Productsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥446m |
| Industrial Productsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥6.7bn |
| Industrial Productsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥6.7bn |
| Industrial Productsreportable segment | segment assets | at 2024-12-31 | ¥8.2bn |
| Industrial Productsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥825m |
| Surgical Productsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥506m |
| Surgical Productsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥129m |
| Surgical Productsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥4.3bn |
| Surgical Productsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥4.3bn |
| Surgical Productsreportable segment | segment assets | at 2024-12-31 | ¥1.7bn |
| Surgical Productsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥2.3bn |
| —segment total | capex | 2024-01-01 → 2024-12-31 | ¥4.1bn |
| —segment total | depreciation | 2024-01-01 → 2024-12-31 | ¥3.7bn |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥77.3bn |
| —segment total | revenue external | 2024-01-01 → 2024-12-31 | ¥77.0bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥214m |
| —segment total | segment assets | at 2024-12-31 | ¥91.9bn |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥20.2bn |
| Dental Productsreportable segment | employees | at 2025-12-31 | 514 pure |
| Industrial Productsreportable segment | employees | at 2025-12-31 | 106 pure |
| Surgical Productsreportable segment | employees | at 2025-12-31 | 175 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,747
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)須 山 誠 一 郎 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)飯 田 圭 一 | |
| Key audit matters consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)歯科事業に係る売上高の期間帰属の適切性 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)注記事項(セグメント情報等) | |
| Reference2 kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)注記事項(連結財務諸表作成のための基本となる重要な事項)４会計方針に関する事項(5)重要な収益及び費用の計上基準 | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row2Member | Original text (Japanese)DCI International, LLC社に係るのれんを含む固定資産の減損 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row2Member | Original text (Japanese)注記事項（重要な会計上の見積り） | |
| Reference2 kam consolidated | FilingDateInstant_Row2Member | Original text (Japanese)（連結損益計算書関係）※７ 減損損失 | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Other information consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)須 山 誠 一 郎 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)飯 田 圭 一 | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)歯科事業に係る売上高の期間帰属の適切性 | |
| Same as kam for consolidated fskam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior4YearDuration | 44857730000 | JPY |
| Net sales (5-year summary) | Prior3YearDuration | 48671452000 | JPY |
| Net sales (5-year summary) | Prior2YearDuration | 59692369000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 77041446000 | JPY |
| Net sales (5-year summary) | CurrentYearDuration | 81179143000 | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration | 13951666000 | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration | 17646562000 | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration | 17193551000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 17283081000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration | 16933969000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior4YearDuration | 10102609000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior3YearDuration | 12471540000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior2YearDuration | 22799807000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 8577872000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYearDuration | -2398213000 | JPY |
| Comprehensive income (5-year summary) | Prior4YearDuration | 10577641000 | JPY |
| Comprehensive income (5-year summary) | Prior3YearDuration | 14165574000 | JPY |
| Comprehensive income (5-year summary) | Prior2YearDuration | 25543693000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 14285641000 | JPY |
| Comprehensive income (5-year summary) | CurrentYearDuration | -77106000 | JPY |
| Net assets (5-year summary) | Prior4YearInstant | 82919473000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |